PROGRAMME
| 08.55 |
Welcome address Hans Adolfsson, Vice Chancellor of Umeå University Yaowen Wu, Director of UCMR |
|
09.15 |
Session I Chairperson: Gemma Atkinson Invited talk Cardiovascular complications during Hemorrhagic fever with renal syndrome Anne-Marie Fors-Connolly, Department of Clinical Microbiology, Umeå University |
|
| 09.30 |
Uncovering novel roles for Beclin 1 in autophagy initiation using chemically induced protein translocation Dale Corkery, Department of Chemistry, Umeå University |
|
| 09.45 |
Cryo-electron tomography of poliovirus-infected cells reveals the role of autophagy membranes in enterovirus assembly and release Selma Dahmane, Department of Medical Biochemistry and Biophysics, Umeå University |
|
| 10.00 |
Infection of hepatitis C virus predominantly blocks Rift Valley fever virus infection in human liver cells Koushikul Islam, Department of Clinical Microbiology, Umeå University |
|
| 10.15 | Coffee break + poster view | |
10.45 |
Session II Chairperson: Marta Bally Keynote SARS-CoV-2 entry into cells and its inhibition Stefan Pöhlmann, University of Göttingen, Germany |
|
| 11.30 |
Invited talk Herpes virus and Alzheimer's disease Hugo Lövheim, Department of Community Medicine and Rehabilitation, Umeå University |
|
| 11.45 |
Deciphering the role of the typhoid toxin in carcinogenesis Maria Lopez Chiloeches, Department of Molecular Biology, Umeå University |
|
| 12.00 | Lunch break | |
13.00 |
Session III Chairperson: Teresa Frisan Invited talk Theoretical models for predicting the origins of the mitochondria Eric Libby, IceLab and Department of Mathematics and Mathematical Statistics, Umeå University |
|
| 13.15 |
The X-factor: An investigation into the role of RsbX in Listeria moncytogenes Ana Oliveira, Department of Molecular Biology, Umeå University |
|
| 13.30 | Poster elevator pitches | |
| 14.30 | Poster sessions + Coffee break | |
| 15.30 | Session IV Chairperson: Constantin Urban Invited talk The CoVUm project: Host-pathogen interactions, immune response and clinical outcome of COVID-19 Johan Normark, Department of Clinical Microbiology, Umeå University |
|
| 15.45 |
Intracellular infection model reveals heterogeneity and significant antibiotic tolerance of uropathogenic Escherichia coli Marta Putrinš, Institute of Technology, University of Tartu, Estonia |
|
| 16.00 |
Development of monoclonal antibodies as antiviral therapy against hantaviruses Janne Tynell, Department of Clinical Microbiology, Umeå University |
|
| 16.15 |
Binding kinetics of human noroviruses to histo-blood group antigens predict susceptibility of human intestinal enteroids to infection Konrad Thorsteinsson, Department of Clinical Microbiology, Umeå University |
|
| 16.30 |
Keynote Emmanuelle Charpentier, Max Planck Unit for the Science of Pathogens, Berlin |
|
| 17.15 |
Closing remarks Constantin Urban |